Table 2.
Histone and non-histone target of dietary HDAC inhibitors
| Class of Compound | Phytochemical | Chemical structure | HAT/HDAC | Histone | Non-histone | Outcome |
|---|---|---|---|---|---|---|
| Short-chain fatty acid | Sodium butyrate |
|
HDAC1 and HDAC334 | H3, H434 | NA | Inhibition of tumor growth, Apoptosis, Cell cycle arrest |
| Isothiocyanates | Sulforaphane |
|
HDAC1, 2, 3, 4 HDAC7, HDAC689–92 |
H3, H489–92 | α-Tubulin93, CtIP*94 | Inhibition of tumor growth, Apoptosis, Cell cycle arrest |
| Allyl-ITC |
|
HDAC95 | H3, H495 | NA | Inhibition of tumor growth, Apoptosis, Cell cycle arrest | |
| BITC |
|
HDAC1 and HDAC396 | H396 | FoxO197 | Inhibition of tumor growth, Apoptosis, Cell cycle arrest, Autophagy | |
| PHITC |
|
HDAC and p30098, HDAC1 and HDAC299 | H3, H499–101 | NA | Apoptosis | |
| PEITC |
|
NA | H3102 | α-Tubulin103 | Attenuating cell proliferation, Apoptosis | |
| Indol-3-carbinol | I3C |
|
HDACs104 HDAC1, HDAC2105, HDAC3106, 107 |
H3, H4104 | NA | Cell cycle arrest, T cell activation |
| Sesquiterpene lactone | Parthenolide |
|
HDAC1108 | H3108 | NA | Inhibition of tumorigenesis, Apoptosis |
| Allium compounds | Diallyl disulfide |
|
N-acetyltransferase109 HDACs |
H3, H4110–113 | NA | Adipocyte differentiation, Apoptosis |
| Allyl mercaptan |
|
HDACs114 | H3, H495, 114–117 | NA | Inhibition of tumor growth, Apoptosis, Cell cycle arrest | |
| Selenium | MSA |
|
HDAC2 and GCN5118 | H3119 H3K18 and H3K9118 | α-Tubulin119 | Inhibition of tumor growth, Apoptosis, Cell cycle arrest |
| Selenite |
|
HDAC120 | H3K9120 | NA | Inhibition of tumor growth, Apoptosis, Cell cycle arrest | |
| MSP |
|
HDAC1 and HDAC8121 | H3K9/14, H4121,26 | NA | Apoptosis | |
| Polyphenols | EGCG |
|
HDAC1, HDAC2, and HDAC3122,123 HAT124 | H3K9/14 H4K5,12,16,H3K 9/18122,125,126 |
p53127, 128 FoxO1129 AR*130 Smad2/3*131 |
Inhibition of tumor growth, Apoptosis, Cell cycle arrest |
| Curcumin |
|
HDAC1, HDAC2132 HDAC3 HDAC4133 HDAC6134 HDAC8135 P300 |
H3, H4135,136 H3K18ac, H4K16ac137 | p53132,138 | Inhibition of tumor growth, Apoptosis, Cell cycle arrest | |
| Resveratrol |
|
SIRT1 HDACs139, SIRT2140 | H3, H4139 | p53141, FXR88, PGC1- α142, FOXO3a143 | Inhibition of tumor growth and cell proliferation, Apoptosis, Cell cycle arrest | |
| Chrysin |
|
HDAC8144 | H3acK14, H4acK12, H4acK16144 | NA | Cell cycle arrest, Inhibition of proliferation | |
| Ellagic acid |
|
HDAC6145, HDAC9146 | NA | NA | Inhibition of proliferation, Apoptosis, Cell cycle arrest | |
| Isoflavones | Quercetin |
|
SIRT6147,148 | H3K56ac148 | NA | Inhibition of a β-catenin pathway, Inhibition of tumor growth, Apoptosis, Cell cycle arrest |
| Apigenin |
|
HDAC1, HDAC3149 | H3, H4149 | NA | p53 activation, Generation of ROS, apoptosis, Inhibition of tumor invasion, Cell cycle arrest | |
| Genistein |
|
HAT1150, HDAC1151 SIRT1152 | H3K9150, 152, H3153, H4154 | NA | Apoptosis, Inhibition of cell proliferation and growth | |
| Luteolin |
|
CBP/p300155, SIRT6147 | H3, H4156 | NA | Apoptosis, Inhibition of invasiveness | |
| Royal jelly | (E)-10-hydroxy-2-decenoic acid (10HDA) |
|
HDAC3157 | H3, H4158 | NA | Apoptosis, Cell cycle arrest |
| Vitamin | Nicotinamide |
|
SIRT1159 | H3160 | p53161, 162, BCL6163, BAZ2a, NPM1, MOF, WRN, Ku70 and Ku80160 | Cell cycle arrest, Apoptosis |
| Tyrosine derived compound | Psammaplin A |
|
HDAC1, HDAC6164, SIRT165 | H3, H4164 | Tubulin164 | Apoptosis, Inhibition of proliferation, Cell cycle arrest |
| Methyl xanthine alkaloid | Caffeine |
|
Hdac1 and Hdac2166 | H3K9 and H3K14166 | NA | Fetal development |
CtIP* is pulled down with lysine antibody in the presence of SFN. AR* and Smad2/3* are deacetylated in the presence of EGCG in human lung cancer cells.
NA: Not available